Delivery Order SPE2DB22D3016-SPE2DB24FBGC7
Award Date
9/5/24
Potential Completion Date
9/6/24
Potential Value
$33K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ENBREL 50 MG/ML SYRINGEML. The contract has a ceiling value of $61,017.59 and a period of performance through October 6, 2023. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of ENBREL 25 MG/0.5 ML syringes, a specialty pharmaceutical product. The contract has a firm fixed price, with a ceiling value of $6,067.06, and a period of performance through May 1, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide ENBREL 50 MG/ML SYRINGE medication. The contract has a ceiling value of $38,962.19 and is a firm fixed-price delivery order, with a period of performance ending on June 26, 2025. The contract is not designated as a set-aside and was open to full and open competition. Amerisourcebergen Drug Corp is the prime contractor, and the contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ENBREL 50 MG/ML SYRINGEML, a pharmaceutical product, with a ceiling value of $16,328.26 and a completion date of May 28, 2025. The contract is a firm fixed-price delivery order and is not a set-aside. Amerisourcebergen Drug Corp also holds a significant Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of ENBREL 50 MG/ML SYRINGEML, a specialty medication, with a ceiling value of $11,087.88 and a period of performance through February 26, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ENBREL 50 MG/ML SYRINGEML, a pharmaceutical product, with a ceiling value of $14,383.25 and a period of performance through June 16, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $28,844.82, is for the delivery of ENBREL 50 MG/ML SYRINGE/ML, a specialty pharmaceutical product. The contract has an ultimate completion date of October 25, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENBREL 50 MG/ML SYRINGEML, a specialty medication, to support federal healthcare programs. The contract has a ceiling value of $88,817.42 and a completion date of January 19, 2023. The contract is a Firm Fixed Price type and does not have a set-aside designation, indicating open...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,059.58, is for the delivery of ENBREL 50 MG/ML SYRINGEML, a specialty pharmaceutical medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,397.04, is for the supply of ENBREL 25 MG/0.5 ML SYRINGE 0.8ML, a specialty pharmaceutical product. The award is a firm fixed-price delivery order contract with a completion date of May 8, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) that...